
The acceptance of medication as a legitimate adjunct to diet and behavior modification in the treatment for obesity is an emerging phenomenon spurred by advances in understanding the zzso basis of body weight regulation and by the demonstration of safe and effective chronic maintenance of weight loss using a zzso zzso The decision to zzso for obesity depends on good clinical judgment based on such considerations as body mass zzso body zzso body fat zzso zzso zzso and zzso conditions, such as diabetes and zzso Several zzso agents and a zzso agent have zzso indications for weight zzso zzso is available over the zzso Clinical trials support the efficacy of zzso and ephedrine or caffeine in producing weight loss, although these agents do not have zzso indications for treatment for zzso In addition, new agents are being developed or are anticipated for zzso The use of existing agents in combination and their use zzso to diet and behavioral approaches to obesity treatment are fertile areas for zzso The expectant attention to this subject is demanded by the imperative that the health in one three people in the United States is adversely affected by zzso 

